相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。What is Chronic Constipation? Definition and Diagnosis
James R Gray
CANADIAN JOURNAL OF GASTROENTEROLOGY (2016)
Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort
Johan Burisch et al.
INFLAMMATORY BOWEL DISEASES (2014)
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort
Z. Vegh et al.
JOURNAL OF CROHNS & COLITIS (2014)
Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases
Marta Sobczak et al.
PHARMACOLOGICAL REPORTS (2014)
New treatment targets for the management of irritable bowel syndrome
Supriya Rao et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2014)
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain
Gerhard Hannig et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Plecanatide, an Oral Guanylate Cyclase C Agonist Acting Locally in the Gastrointestinal Tract, Is Safe and Well-Tolerated in Single Doses
Kunwar Shailubhai et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate
Joel Castro et al.
GASTROENTEROLOGY (2013)
Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis
Giovanni M. Pitari
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Robert W. Busby et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
Satish Rao et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome
Bin Feng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Non-IBD colitides (eosinophilic, microscopic)
Eugene F. Yen et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Rebecca M. Lovell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome
M. Camilleri
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Guanylate cyclase-C receptor activation: unexpected biology
Stuart M. Brierley
CURRENT OPINION IN PHARMACOLOGY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
Epithelial barrier biology: good fences make good neighbours
Emmanuelle Moens et al.
IMMUNOLOGY (2012)
The guanylin peptide family and the proposed gastrointestinal-renal natriuretic signaling axis
Thomas Mueller et al.
KIDNEY INTERNATIONAL (2012)
Peripheral Mechanisms in Irritable Bowel Syndrome
Michael Camilleri
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Brain-gut interactions in IBS
Jakub Fichna et al.
FRONTIERS IN PHARMACOLOGY (2012)
News from the End of the Gut-How the Highly Segmental Pattern of Colonic HCO3- Transport Relates to Absorptive Function and Mucosal Integrity
Oliver Bachmann et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Uroguanylin Regulates Net Fluid Secretion via the NHE2 Isoform of the Na+/H+ Exchanger in an Intestinal Cellular Model
Roxana Toriano et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Transmembrane guanylate cyclase in intestinal pathophysiology
Kris A. Steinbrecher et al.
CURRENT OPINION IN GASTROENTEROLOGY (2011)
Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis
Alexander C. Ford et al.
GUT (2011)
Two Randomized Trials of Linaclotide for Chronic Constipation
Anthony J. Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
Robert W. Busby et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy
Anja Schirbel et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain
H. Eutamene et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Bacterial Heat-Stable Enterotoxins: Translation of Pathogenic Peptides into Novel Targeted Diagnostics and Therapeutics
Jieru E. Lin et al.
TOXINS (2010)
Review: Current trends in inflammatory bowel disease: the natural history
Ebbe Langholz
Therapeutic Advances in Gastroenterology (2010)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Serotonergic agents and the irritable bowel syndrome: what goes wrong?
Robin Spiller
CURRENT OPINION IN PHARMACOLOGY (2008)
Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis
Chad K. Heazlewood et al.
PLOS MEDICINE (2008)
Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily
M. Cottone et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2006)
The epidemiology of inflammatory bowel disease in Canada: A population-based study
Charles N. Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome
J. H. Park et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease
DSA Sanders
JOURNAL OF CLINICAL PATHOLOGY (2005)
Epidemiology of constipation in North America: A systematic review
PDR Higgins et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population
GR Locke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C
AB Vaandrager
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Epidemiology of inflammatory bowel disease
EV Loftus et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2002)
Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells
GM Pitari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Expression of guanylin is downregulated in mouse and human intestinal adenomas
KA Steinbrecher et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon
AB Vaandrager et al.
GASTROENTEROLOGY (2000)